These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7064719)

  • 1. Biliary excretion of bisacodyl and picosulphate in man: studies in gallstone patients after biliary tract surgery.
    Sund RB; Roland M; Kristiansen S; Salvesen B
    Acta Pharmacol Toxicol (Copenh); 1982 Jan; 50(1):50-7. PubMed ID: 7064719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterohepatic circulation, urinary excretion and laxative action of some bisacodyl derivatives after intragastric administration in the rat.
    Sund RB; Songedal K; Harestad T; Salvesen B; Kristiansen S
    Acta Pharmacol Toxicol (Copenh); 1981 Jan; 48(1):73-80. PubMed ID: 7223440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal handling of bisacodyl and picosulphate by everted sacs of the rat jejunum and stripped colon.
    Hillestad B; Sund RB; Buajordet M
    Acta Pharmacol Toxicol (Copenh); 1982 Oct; 51(4):388-94. PubMed ID: 7180502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bis-(p-hydroxyphenyl)-pyridyl-2-methane: The common laxative principle of Bisacodyl and sodium picosulfate.
    Jauch R; Hankwitz R; Beschke K; Pelzer H
    Arzneimittelforschung; 1975 Nov; 25(11):1796-1800. PubMed ID: 1243088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the type of dietary fat on biliary lipid composition and bile lithogenicity in humans with cholesterol gallstone disease.
    Yago MD; González V; Serrano P; Calpena R; Martínez MA; Martínez-Victoria E; Mañas M
    Nutrition; 2005 Mar; 21(3):339-47. PubMed ID: 15797676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary lipid excretion in patients with pigment gallstones. A comparison with cholesterol gallstone patients.
    Wagner CI; Trotman BW; Soloway RD
    Am J Dig Dis; 1978 Jan; 23(1):85-8. PubMed ID: 619630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity.
    Shaffer EA; Small DM
    J Clin Invest; 1977 May; 59(5):828-40. PubMed ID: 856870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake, conjugation and transport of laxative diphenols by everted sacs of the rat jejunum and stripped colon.
    Sund RB; Hillestad B
    Acta Pharmacol Toxicol (Copenh); 1982 Oct; 51(4):377-87. PubMed ID: 6897480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary lipids, lithogenic index and biliary drug concentrations during etofibrate and bezafibrate treatment.
    Raedsch R; Plachky J; Wolf N; Simonis G
    Eur J Drug Metab Pharmacokinet; 1995; 20(2):113-8. PubMed ID: 8582435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A clinical study in postoperative bile excretion of cefuzonam].
    Hirano M; Fujimura M; Yamamoto A; Yamamoto I; Nishimura K; Takahara H; Hirano T; Mori A
    Jpn J Antibiot; 1991 Jan; 44(1):9-13. PubMed ID: 2041151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone-free subjects: deoxycholic acid does not contribute to formation of cholesterol gallstones.
    Gustafsson U; Sahlin S; Einarsson C
    Eur J Clin Invest; 2000 Dec; 30(12):1099-106. PubMed ID: 11122325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biliary tract excretion of ofloxacin in man.
    Kazmierczak A; Pechinot A; Duez JM; Haas O; Favre JP
    Drugs; 1987; 34 Suppl 1():39-43. PubMed ID: 3481327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary lipid output during three meals and an overnight fast. I. Relationship to bile acid pool size and cholesterol saturation of bile in gallstone and control subjects.
    Northfield TC; Hofmann AF
    Gut; 1975 Jan; 16(1):1-11. PubMed ID: 806491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of short term lipid infusion on plasma and hepatic bile lipids in humans.
    Pakula R; Konikoff FM; Moser AM; Greif F; Tietz A; Gilat T; Rubin M
    Gut; 1999 Sep; 45(3):453-8. PubMed ID: 10446118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium and calcium binding in human gallstone disease.
    Dawes LG; Rege RV
    Arch Surg; 1990 Dec; 125(12):1606-9. PubMed ID: 2244815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary excretion and concentration of cefazolin.
    Ram MD; Watanatittan S
    Am J Gastroenterol; 1976 Dec; 66(6):540-5. PubMed ID: 1020741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study on the concentrations of levofloxacin in the gallbladder tissue and bile of patients].
    Hukagawa H; Noga K
    Jpn J Antibiot; 1992 Mar; 45(3):253-7. PubMed ID: 1512921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary excretion of cefuroxime. Experimental and human study.
    Brogard JM; Pinget M; Arnaud JP; Dorner M; Lavillaureix J
    Chemotherapy; 1981; 27(1):18-28. PubMed ID: 7215002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased biliary calcium in cholesterol gallstone formation.
    Strichartz SD; Abedin MZ; Abdou MS; Roslyn JJ
    Am J Surg; 1988 Jan; 155(1):131-7. PubMed ID: 3341526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Sodium Picosulfate/Magnesium Citrate for Bowel Preparation in a Physically Disabled Outpatient Population: A Randomized, Endoscopist-Blinded Comparison With Ascorbic Acid-Enriched Polyethylene Glycol Solution Plus Bisacodyl (The PICO-MOVI Study).
    Mathus-Vliegen EMH; van der Vliet K; Wignand-van der Storm IJ; Stadwijk JS
    Dis Colon Rectum; 2018 Feb; 61(2):239-249. PubMed ID: 29337780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.